Synthesis and evaluation of potent and selective beta(3) adrenergic receptor agonists containing acylsulfonamide, sulfonylsulfonamide, and sulfonylurea carboxylic acid isosteres

Starting from phenethanolamine aniline leads 3a and 3b, we have identified a series of functionally potent and selective beta(3) adrenergic receptor (AR) agonists containing acylsulfonamide, sulfonylsulfonamide, or sulfonylurea groups within the aniline phenethanolamine series. In beta(3), beta(2),...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medicinal chemistry 2002-01, Vol.45 (3), p.567-583
Hauptverfasser: Uehling, David E, Donaldson, Kelly H, Deaton, David N, Hyman, Clifton E, Sugg, Elizabeth E, Barrett, David G, Hughes, Robert G, Reitter, Barbara, Adkison, Kim K, Lancaster, Mary E, Lee, Frank, Hart, Robert, Paulik, Mark A, Sherman, Bryan W, True, Timothy, Cowan, Conrad
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 583
container_issue 3
container_start_page 567
container_title Journal of medicinal chemistry
container_volume 45
creator Uehling, David E
Donaldson, Kelly H
Deaton, David N
Hyman, Clifton E
Sugg, Elizabeth E
Barrett, David G
Hughes, Robert G
Reitter, Barbara
Adkison, Kim K
Lancaster, Mary E
Lee, Frank
Hart, Robert
Paulik, Mark A
Sherman, Bryan W
True, Timothy
Cowan, Conrad
description Starting from phenethanolamine aniline leads 3a and 3b, we have identified a series of functionally potent and selective beta(3) adrenergic receptor (AR) agonists containing acylsulfonamide, sulfonylsulfonamide, or sulfonylurea groups within the aniline phenethanolamine series. In beta(3), beta(2), and beta(1) AR cAMP functional assays, 3a and other right-hand side (RHS) carboxylate analogues were found to be full agonists that were modestly selective against beta(1) or beta(2) ARs, while analogues lacking RHS acid functionality were active at beta(3) AR but not selective. Replacement of the carboxylate with acylthiazole and acylmethylsulfone gave potent, but only modestly selective, compounds. Increasing the size of the RHS sulfonamide substituent with phenyl or p-toluene afforded compounds with good potency and functional selectivity (beta(3) AR pEC(50) greater than 8; beta(1) and beta(2) AR selectivity greater than 40- and 500-fold, respectively). Our SAR studies suggest that the potency and selectivity profile of the best analogues reported here is a result of both the steric bulk and acidity of the RHS sulfonamide NH group. Although all of the analogues had a pharmacokinetic half-life of less than 2 h, acylsulfonamides 43 and 44 did show moderately low clearance in dogs. These two compounds were further evaluated by thermographic imaging in mice and were found to produce a robust thermogenic response via oral administration.
doi_str_mv 10.1021/jm0101500
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_71416665</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71416665</sourcerecordid><originalsourceid>FETCH-LOGICAL-p139t-efe22b35cb4ca9ba075abfb1fb36bb7f0c7e6118e9fa160defd8a1dd4f0d0f3e3</originalsourceid><addsrcrecordid>eNpdUMtKAzEUzUKxtbrwByQrUbB6M2ln7FKKLyi4UNflJrmpKTPJmGSK_Sz_0NLWjavDeXAOHMbOBNwIKMTtsgEBYgxwwPoARTEsykL22HFKSwCQopBHrCfEHZQVTPrs523t8ycllzh6w2mFdYfZBc-D5W3I5PPWSFSTzm5FXFHGS3nF0UTyFBdO80ia2hwix0XwLuXEdfAZnXd-wVGv69TVNnhsnKFrviP_xO3G3ugiIdcYVfhe15t61M5wl0LKFCmdsEOLdaLTPQ7Yx-PD-_R5OHt9epnez4atkJM8JEtFoeRYq5HGiUKoxqisElbJUqnKgq6o3PxAE4uiBEPW3KEwZmTBgJUkB-xi19vG8NVRyvPGJU11jZ5Cl-aVGImyLMeb4Pk-2KmGzLyNrsG4nv-dLH8BSpGDOw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71416665</pqid></control><display><type>article</type><title>Synthesis and evaluation of potent and selective beta(3) adrenergic receptor agonists containing acylsulfonamide, sulfonylsulfonamide, and sulfonylurea carboxylic acid isosteres</title><source>MEDLINE</source><source>ACS Publications</source><creator>Uehling, David E ; Donaldson, Kelly H ; Deaton, David N ; Hyman, Clifton E ; Sugg, Elizabeth E ; Barrett, David G ; Hughes, Robert G ; Reitter, Barbara ; Adkison, Kim K ; Lancaster, Mary E ; Lee, Frank ; Hart, Robert ; Paulik, Mark A ; Sherman, Bryan W ; True, Timothy ; Cowan, Conrad</creator><creatorcontrib>Uehling, David E ; Donaldson, Kelly H ; Deaton, David N ; Hyman, Clifton E ; Sugg, Elizabeth E ; Barrett, David G ; Hughes, Robert G ; Reitter, Barbara ; Adkison, Kim K ; Lancaster, Mary E ; Lee, Frank ; Hart, Robert ; Paulik, Mark A ; Sherman, Bryan W ; True, Timothy ; Cowan, Conrad</creatorcontrib><description>Starting from phenethanolamine aniline leads 3a and 3b, we have identified a series of functionally potent and selective beta(3) adrenergic receptor (AR) agonists containing acylsulfonamide, sulfonylsulfonamide, or sulfonylurea groups within the aniline phenethanolamine series. In beta(3), beta(2), and beta(1) AR cAMP functional assays, 3a and other right-hand side (RHS) carboxylate analogues were found to be full agonists that were modestly selective against beta(1) or beta(2) ARs, while analogues lacking RHS acid functionality were active at beta(3) AR but not selective. Replacement of the carboxylate with acylthiazole and acylmethylsulfone gave potent, but only modestly selective, compounds. Increasing the size of the RHS sulfonamide substituent with phenyl or p-toluene afforded compounds with good potency and functional selectivity (beta(3) AR pEC(50) greater than 8; beta(1) and beta(2) AR selectivity greater than 40- and 500-fold, respectively). Our SAR studies suggest that the potency and selectivity profile of the best analogues reported here is a result of both the steric bulk and acidity of the RHS sulfonamide NH group. Although all of the analogues had a pharmacokinetic half-life of less than 2 h, acylsulfonamides 43 and 44 did show moderately low clearance in dogs. These two compounds were further evaluated by thermographic imaging in mice and were found to produce a robust thermogenic response via oral administration.</description><identifier>ISSN: 0022-2623</identifier><identifier>DOI: 10.1021/jm0101500</identifier><identifier>PMID: 11806709</identifier><language>eng</language><publisher>United States</publisher><subject>Adrenergic beta-Agonists - chemical synthesis ; Adrenergic beta-Agonists - chemistry ; Adrenergic beta-Agonists - pharmacology ; Aniline Compounds - chemical synthesis ; Aniline Compounds - chemistry ; Aniline Compounds - pharmacology ; Animals ; Biological Availability ; Body Temperature - drug effects ; CHO Cells ; Chromatography, High Pressure Liquid ; Cricetinae ; Cyclic AMP - biosynthesis ; Dogs ; Humans ; Magnetic Resonance Spectroscopy ; Male ; Mass Spectrometry ; Mice ; Radioligand Assay ; Receptors, Adrenergic, beta-3 - drug effects ; Stereoisomerism ; Structure-Activity Relationship ; Sulfonamides - chemical synthesis ; Sulfonamides - chemistry ; Sulfonamides - pharmacology ; Sulfonylurea Compounds - chemical synthesis ; Sulfonylurea Compounds - chemistry ; Sulfonylurea Compounds - pharmacology ; Thermography</subject><ispartof>Journal of medicinal chemistry, 2002-01, Vol.45 (3), p.567-583</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11806709$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Uehling, David E</creatorcontrib><creatorcontrib>Donaldson, Kelly H</creatorcontrib><creatorcontrib>Deaton, David N</creatorcontrib><creatorcontrib>Hyman, Clifton E</creatorcontrib><creatorcontrib>Sugg, Elizabeth E</creatorcontrib><creatorcontrib>Barrett, David G</creatorcontrib><creatorcontrib>Hughes, Robert G</creatorcontrib><creatorcontrib>Reitter, Barbara</creatorcontrib><creatorcontrib>Adkison, Kim K</creatorcontrib><creatorcontrib>Lancaster, Mary E</creatorcontrib><creatorcontrib>Lee, Frank</creatorcontrib><creatorcontrib>Hart, Robert</creatorcontrib><creatorcontrib>Paulik, Mark A</creatorcontrib><creatorcontrib>Sherman, Bryan W</creatorcontrib><creatorcontrib>True, Timothy</creatorcontrib><creatorcontrib>Cowan, Conrad</creatorcontrib><title>Synthesis and evaluation of potent and selective beta(3) adrenergic receptor agonists containing acylsulfonamide, sulfonylsulfonamide, and sulfonylurea carboxylic acid isosteres</title><title>Journal of medicinal chemistry</title><addtitle>J Med Chem</addtitle><description>Starting from phenethanolamine aniline leads 3a and 3b, we have identified a series of functionally potent and selective beta(3) adrenergic receptor (AR) agonists containing acylsulfonamide, sulfonylsulfonamide, or sulfonylurea groups within the aniline phenethanolamine series. In beta(3), beta(2), and beta(1) AR cAMP functional assays, 3a and other right-hand side (RHS) carboxylate analogues were found to be full agonists that were modestly selective against beta(1) or beta(2) ARs, while analogues lacking RHS acid functionality were active at beta(3) AR but not selective. Replacement of the carboxylate with acylthiazole and acylmethylsulfone gave potent, but only modestly selective, compounds. Increasing the size of the RHS sulfonamide substituent with phenyl or p-toluene afforded compounds with good potency and functional selectivity (beta(3) AR pEC(50) greater than 8; beta(1) and beta(2) AR selectivity greater than 40- and 500-fold, respectively). Our SAR studies suggest that the potency and selectivity profile of the best analogues reported here is a result of both the steric bulk and acidity of the RHS sulfonamide NH group. Although all of the analogues had a pharmacokinetic half-life of less than 2 h, acylsulfonamides 43 and 44 did show moderately low clearance in dogs. These two compounds were further evaluated by thermographic imaging in mice and were found to produce a robust thermogenic response via oral administration.</description><subject>Adrenergic beta-Agonists - chemical synthesis</subject><subject>Adrenergic beta-Agonists - chemistry</subject><subject>Adrenergic beta-Agonists - pharmacology</subject><subject>Aniline Compounds - chemical synthesis</subject><subject>Aniline Compounds - chemistry</subject><subject>Aniline Compounds - pharmacology</subject><subject>Animals</subject><subject>Biological Availability</subject><subject>Body Temperature - drug effects</subject><subject>CHO Cells</subject><subject>Chromatography, High Pressure Liquid</subject><subject>Cricetinae</subject><subject>Cyclic AMP - biosynthesis</subject><subject>Dogs</subject><subject>Humans</subject><subject>Magnetic Resonance Spectroscopy</subject><subject>Male</subject><subject>Mass Spectrometry</subject><subject>Mice</subject><subject>Radioligand Assay</subject><subject>Receptors, Adrenergic, beta-3 - drug effects</subject><subject>Stereoisomerism</subject><subject>Structure-Activity Relationship</subject><subject>Sulfonamides - chemical synthesis</subject><subject>Sulfonamides - chemistry</subject><subject>Sulfonamides - pharmacology</subject><subject>Sulfonylurea Compounds - chemical synthesis</subject><subject>Sulfonylurea Compounds - chemistry</subject><subject>Sulfonylurea Compounds - pharmacology</subject><subject>Thermography</subject><issn>0022-2623</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdUMtKAzEUzUKxtbrwByQrUbB6M2ln7FKKLyi4UNflJrmpKTPJmGSK_Sz_0NLWjavDeXAOHMbOBNwIKMTtsgEBYgxwwPoARTEsykL22HFKSwCQopBHrCfEHZQVTPrs523t8ycllzh6w2mFdYfZBc-D5W3I5PPWSFSTzm5FXFHGS3nF0UTyFBdO80ia2hwix0XwLuXEdfAZnXd-wVGv69TVNnhsnKFrviP_xO3G3ugiIdcYVfhe15t61M5wl0LKFCmdsEOLdaLTPQ7Yx-PD-_R5OHt9epnez4atkJM8JEtFoeRYq5HGiUKoxqisElbJUqnKgq6o3PxAE4uiBEPW3KEwZmTBgJUkB-xi19vG8NVRyvPGJU11jZ5Cl-aVGImyLMeb4Pk-2KmGzLyNrsG4nv-dLH8BSpGDOw</recordid><startdate>20020131</startdate><enddate>20020131</enddate><creator>Uehling, David E</creator><creator>Donaldson, Kelly H</creator><creator>Deaton, David N</creator><creator>Hyman, Clifton E</creator><creator>Sugg, Elizabeth E</creator><creator>Barrett, David G</creator><creator>Hughes, Robert G</creator><creator>Reitter, Barbara</creator><creator>Adkison, Kim K</creator><creator>Lancaster, Mary E</creator><creator>Lee, Frank</creator><creator>Hart, Robert</creator><creator>Paulik, Mark A</creator><creator>Sherman, Bryan W</creator><creator>True, Timothy</creator><creator>Cowan, Conrad</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20020131</creationdate><title>Synthesis and evaluation of potent and selective beta(3) adrenergic receptor agonists containing acylsulfonamide, sulfonylsulfonamide, and sulfonylurea carboxylic acid isosteres</title><author>Uehling, David E ; Donaldson, Kelly H ; Deaton, David N ; Hyman, Clifton E ; Sugg, Elizabeth E ; Barrett, David G ; Hughes, Robert G ; Reitter, Barbara ; Adkison, Kim K ; Lancaster, Mary E ; Lee, Frank ; Hart, Robert ; Paulik, Mark A ; Sherman, Bryan W ; True, Timothy ; Cowan, Conrad</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p139t-efe22b35cb4ca9ba075abfb1fb36bb7f0c7e6118e9fa160defd8a1dd4f0d0f3e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adrenergic beta-Agonists - chemical synthesis</topic><topic>Adrenergic beta-Agonists - chemistry</topic><topic>Adrenergic beta-Agonists - pharmacology</topic><topic>Aniline Compounds - chemical synthesis</topic><topic>Aniline Compounds - chemistry</topic><topic>Aniline Compounds - pharmacology</topic><topic>Animals</topic><topic>Biological Availability</topic><topic>Body Temperature - drug effects</topic><topic>CHO Cells</topic><topic>Chromatography, High Pressure Liquid</topic><topic>Cricetinae</topic><topic>Cyclic AMP - biosynthesis</topic><topic>Dogs</topic><topic>Humans</topic><topic>Magnetic Resonance Spectroscopy</topic><topic>Male</topic><topic>Mass Spectrometry</topic><topic>Mice</topic><topic>Radioligand Assay</topic><topic>Receptors, Adrenergic, beta-3 - drug effects</topic><topic>Stereoisomerism</topic><topic>Structure-Activity Relationship</topic><topic>Sulfonamides - chemical synthesis</topic><topic>Sulfonamides - chemistry</topic><topic>Sulfonamides - pharmacology</topic><topic>Sulfonylurea Compounds - chemical synthesis</topic><topic>Sulfonylurea Compounds - chemistry</topic><topic>Sulfonylurea Compounds - pharmacology</topic><topic>Thermography</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Uehling, David E</creatorcontrib><creatorcontrib>Donaldson, Kelly H</creatorcontrib><creatorcontrib>Deaton, David N</creatorcontrib><creatorcontrib>Hyman, Clifton E</creatorcontrib><creatorcontrib>Sugg, Elizabeth E</creatorcontrib><creatorcontrib>Barrett, David G</creatorcontrib><creatorcontrib>Hughes, Robert G</creatorcontrib><creatorcontrib>Reitter, Barbara</creatorcontrib><creatorcontrib>Adkison, Kim K</creatorcontrib><creatorcontrib>Lancaster, Mary E</creatorcontrib><creatorcontrib>Lee, Frank</creatorcontrib><creatorcontrib>Hart, Robert</creatorcontrib><creatorcontrib>Paulik, Mark A</creatorcontrib><creatorcontrib>Sherman, Bryan W</creatorcontrib><creatorcontrib>True, Timothy</creatorcontrib><creatorcontrib>Cowan, Conrad</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Uehling, David E</au><au>Donaldson, Kelly H</au><au>Deaton, David N</au><au>Hyman, Clifton E</au><au>Sugg, Elizabeth E</au><au>Barrett, David G</au><au>Hughes, Robert G</au><au>Reitter, Barbara</au><au>Adkison, Kim K</au><au>Lancaster, Mary E</au><au>Lee, Frank</au><au>Hart, Robert</au><au>Paulik, Mark A</au><au>Sherman, Bryan W</au><au>True, Timothy</au><au>Cowan, Conrad</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis and evaluation of potent and selective beta(3) adrenergic receptor agonists containing acylsulfonamide, sulfonylsulfonamide, and sulfonylurea carboxylic acid isosteres</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J Med Chem</addtitle><date>2002-01-31</date><risdate>2002</risdate><volume>45</volume><issue>3</issue><spage>567</spage><epage>583</epage><pages>567-583</pages><issn>0022-2623</issn><abstract>Starting from phenethanolamine aniline leads 3a and 3b, we have identified a series of functionally potent and selective beta(3) adrenergic receptor (AR) agonists containing acylsulfonamide, sulfonylsulfonamide, or sulfonylurea groups within the aniline phenethanolamine series. In beta(3), beta(2), and beta(1) AR cAMP functional assays, 3a and other right-hand side (RHS) carboxylate analogues were found to be full agonists that were modestly selective against beta(1) or beta(2) ARs, while analogues lacking RHS acid functionality were active at beta(3) AR but not selective. Replacement of the carboxylate with acylthiazole and acylmethylsulfone gave potent, but only modestly selective, compounds. Increasing the size of the RHS sulfonamide substituent with phenyl or p-toluene afforded compounds with good potency and functional selectivity (beta(3) AR pEC(50) greater than 8; beta(1) and beta(2) AR selectivity greater than 40- and 500-fold, respectively). Our SAR studies suggest that the potency and selectivity profile of the best analogues reported here is a result of both the steric bulk and acidity of the RHS sulfonamide NH group. Although all of the analogues had a pharmacokinetic half-life of less than 2 h, acylsulfonamides 43 and 44 did show moderately low clearance in dogs. These two compounds were further evaluated by thermographic imaging in mice and were found to produce a robust thermogenic response via oral administration.</abstract><cop>United States</cop><pmid>11806709</pmid><doi>10.1021/jm0101500</doi><tpages>17</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-2623
ispartof Journal of medicinal chemistry, 2002-01, Vol.45 (3), p.567-583
issn 0022-2623
language eng
recordid cdi_proquest_miscellaneous_71416665
source MEDLINE; ACS Publications
subjects Adrenergic beta-Agonists - chemical synthesis
Adrenergic beta-Agonists - chemistry
Adrenergic beta-Agonists - pharmacology
Aniline Compounds - chemical synthesis
Aniline Compounds - chemistry
Aniline Compounds - pharmacology
Animals
Biological Availability
Body Temperature - drug effects
CHO Cells
Chromatography, High Pressure Liquid
Cricetinae
Cyclic AMP - biosynthesis
Dogs
Humans
Magnetic Resonance Spectroscopy
Male
Mass Spectrometry
Mice
Radioligand Assay
Receptors, Adrenergic, beta-3 - drug effects
Stereoisomerism
Structure-Activity Relationship
Sulfonamides - chemical synthesis
Sulfonamides - chemistry
Sulfonamides - pharmacology
Sulfonylurea Compounds - chemical synthesis
Sulfonylurea Compounds - chemistry
Sulfonylurea Compounds - pharmacology
Thermography
title Synthesis and evaluation of potent and selective beta(3) adrenergic receptor agonists containing acylsulfonamide, sulfonylsulfonamide, and sulfonylurea carboxylic acid isosteres
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T16%3A19%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis%20and%20evaluation%20of%20potent%20and%20selective%20beta(3)%20adrenergic%20receptor%20agonists%20containing%20acylsulfonamide,%20sulfonylsulfonamide,%20and%20sulfonylurea%20carboxylic%20acid%20isosteres&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Uehling,%20David%20E&rft.date=2002-01-31&rft.volume=45&rft.issue=3&rft.spage=567&rft.epage=583&rft.pages=567-583&rft.issn=0022-2623&rft_id=info:doi/10.1021/jm0101500&rft_dat=%3Cproquest_pubme%3E71416665%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71416665&rft_id=info:pmid/11806709&rfr_iscdi=true